Raymond James & Associates Ab Cellera Biologics Inc. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Raymond James & Associates holds 12,458 shares of ABCL stock, worth $36,377. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,458

Previous 13,569 8.19%

Holding current value

$36,377

Previous $40,000 20.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$2.39 - $3.49 $2,655 - $3,877	-1,111 Reduced 8.19%	12,458 $32,000
Q2 2024 Jul 19, 2024	SELL	$2.73 - $4.73 $286 - $496	-105 Reduced 0.77%	13,569 $40,000
Q1 2024 Apr 22, 2024	BUY	$4.29 - $5.97 $5,525 - $7,689	1,288 Added 10.4%	13,674 $61,000
Q4 2023 Jan 16, 2024	SELL	$3.91 - $5.93 $14,646 - $22,213	-3,746 Reduced 23.22%	12,386 $70,000
Q3 2023 Oct 24, 2023	SELL	$4.6 - $7.95 $168,783 - $291,701	-36,692 Reduced 69.46%	16,132 $74,000
Q2 2023 Jul 25, 2023	BUY	$5.66 - $7.59 $32,211 - $43,194	5,691 Added 12.07%	52,824 $341,000
Q1 2023 Apr 14, 2023	BUY	$7.31 - $11.18 $195,498 - $298,997	26,744 Added 131.17%	47,133 $355,000
Q4 2022 Feb 08, 2023	SELL	$9.48 - $14.52 $19,680 - $30,143	-2,076 Reduced 9.24%	20,389 $206,000
Q3 2022 Oct 25, 2022	BUY	$9.2 - $13.68 $39,440 - $58,646	4,287 Added 23.58%	22,465 $222,000
Q2 2022 Aug 12, 2022	BUY	$5.72 - $10.65 $12,503 - $23,280	2,186 Added 13.67%	18,178 $194,000
Q1 2022 May 11, 2022	SELL	$7.46 - $14.14 $423,235 - $802,218	-56,734 Reduced 78.01%	15,992 $156,000
Q4 2021 Feb 08, 2022	SELL	$12.99 - $17.73 $696,588 - $950,771	-53,625 Reduced 42.44%	72,726 $1.04 Million
Q3 2021 Nov 02, 2021	BUY	$14.85 - $21.34 $110,602 - $158,940	7,448 Added 6.26%	126,351 $2.53 Million
Q2 2021 Aug 11, 2021	BUY	$20.19 - $34.17 $928,881 - $1.57 Million	46,007 Added 63.11%	118,903 $2.62 Million
Q1 2021 May 14, 2021	BUY	$23.29 - $53.2 $1.7 Million - $3.88 Million	72,896 New	72,896 $2.48 Million

Others Institutions Holding ABCL

# of Institutions

154

Shares Held

109M

Call Options Held

153K

Put Options Held

194K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $833M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Ab Cellera Biologics Inc. Transaction History